The Ankylosing Spondylitis (Bekhterev’s Disease) drugs in development market research report provides comprehensive information on the therapeutics under development for Ankylosing Spondylitis (Bekhterev’s Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses key aspects of the companies and drugs in development for Ankylosing Spondylitis (Bekhterev’s Disease). Buy the report here.
Smarter leaders trust GlobalData
The report also covers the descriptive pharmacological action of the therapeutics and the latest news and press releases. Additionally, the report provides an overview of the key players involved in therapeutic development for Ankylosing Spondylitis (Bekhterev’s Disease) and features dormant and discontinued products.
GlobalData tracks 69 drugs in development for Ankylosing Spondylitis (Bekhterev’s Disease) by 60 companies/universities/institutes. The top development phase for Ankylosing Spondylitis (Bekhterev’s Disease) is phase i with 17 drugs in that stage. The Ankylosing Spondylitis (Bekhterev’s Disease) pipeline has 68 drugs in development by companies and one by universities/ institutes. Some of the companies in the Ankylosing Spondylitis (Bekhterev’s Disease) pipeline products market are: Huabo Biopharm (Shanghai), Bioviz Technologies and Jiangsu Hengrui Medicine.
The key targets in the Ankylosing Spondylitis (Bekhterev’s Disease) pipeline products market include Tumor Necrosis Factor, Interleukin 17A, and Tyrosine Protein Kinase JAK1.
The key mechanisms of action in the Ankylosing Spondylitis (Bekhterev’s Disease) pipeline product include Tumor Necrosis Factor Inhibitor with 22 drugs in Pre-Registration. The Ankylosing Spondylitis (Bekhterev’s Disease) pipeline products include six routes of administration with the top ROA being Subcutaneous and eight key molecule types in the Ankylosing Spondylitis (Bekhterev’s Disease) pipeline products market including Monoclonal Antibody, and Small Molecule.
Ankylosing Spondylitis (Bekhterev’s Disease) overview
Ankylosing spondylitis is a type of arthritis that affects the spine. Ankylosing spondylitis symptoms include pain and stiffness from the neck down to the lower back. The spine’s bones (vertebrae) may grow or fuse together, resulting in a rigid spine. These changes may be mild or severe, and may lead to a stooped-over posture.
For a complete picture of Ankylosing Spondylitis (Bekhterev’s Disease)’s pipeline drug market, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s pipeline drugs offers detailed profiles of pharmaceutical drugs in all stages of pre-clinical and clinical development, from discovery through to pre-registration. Coverage is limited to novel human medicinal drugs and biosimilars seeking market approval proprietary and is one of two primary repositories of pharmaceutical drug information offered by GlobalData through its Pharmaceutical Intelligence Center.
